BLOG: We know that isolation is one of the drivers of suicide in doctors. But listening to how doctors are affected in their heroic work on the front lines of the COVID-19 epidemic gives me hope that barriers to openly sharing one’s personal distress are lowering.

The US Food and Drug Administration has accepted the filing of a New Drug Application for an investigational amphetamine for the treatment of attention-deficit/hyperactivity disorder specifically designed to resist manipulation.

A “small but important” number of people will develop COVID-19–related psychosis, according to a rapid review published online in Schizophrenia Research.

Internet-delivered cognitive behavioral therapy was noninferior to conventional face-to-face CBT among patients with health anxiety, or hypochondriasis, according to a study published online in JAMA Psychiatry.